Bioscience Valuation's R&D Risk Model
Customers may license Bioscience Valuation's programs for their own use. Bioscience Valuation's R&D Risk Model enables our clients to fine-tune the probability of success for each development phase by considering:
- therapeutic area or specific indication,
- mode of action,
- molecule type,
- degree of innovation,
- route of administration.
The model suggests particular success probabilities based on benchmark studies; however, the user can adjust individual probabilities to adapt the model to his specific needs. Furthermore, if combined with cost estimates, the model calculates the 'expected value of perfect information' that can aid investment decisions.
Please contact us for receiving further information, or to order the model.